Show simple item record

dc.contributor.authorOnat, Altan
dc.contributor.authorKaradeniz, Yusuf
dc.contributor.authorYuksel, Husniye
dc.contributor.authorAdemoglu, Evin
dc.contributor.authorCan, Gunay
dc.contributor.authorAltay, Servet
dc.contributor.authorYuksel, Murat
dc.date.accessioned2021-03-05T20:59:44Z
dc.date.available2021-03-05T20:59:44Z
dc.date.issued2017
dc.identifier.citationOnat A., Altay S., Yuksel M., Karadeniz Y., Can G., Yuksel H., Ademoglu E., "Low acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation?", ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, ss.97-106, 2017
dc.identifier.issn2149-2263
dc.identifier.othervv_1032021
dc.identifier.otherav_d6d35756-8c7a-4fbf-b573-1da72c6cfd59
dc.identifier.urihttp://hdl.handle.net/20.500.12627/141766
dc.identifier.urihttps://doi.org/10.14744/anatoljcardiol.2016.7024
dc.description.abstractObjective: We investigated the possible association of serum acylation stimulating protein (ASP) with cardiometabolic disorders and the evidence of autoimmune activation.
dc.language.isoeng
dc.subjectTıp
dc.subjectKardiyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.titleLow acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation?
dc.typeMakale
dc.relation.journalANATOLIAN JOURNAL OF CARDIOLOGY
dc.contributor.departmentTrakya Üniversitesi , ,
dc.identifier.volume17
dc.identifier.issue2
dc.identifier.startpage97
dc.identifier.endpage106
dc.contributor.firstauthorID91137


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record